Latest Shareholder Approvals News

Anagenics Limited reports a significant turnaround with profitable trading in the second quarter of FY26, driven by strong brand performance and a successful capital raise. The company is poised for growth with expanding product lines and international ambitions.

Group One Capital Limited has reported a remarkable 246% increase in revenue for the half-year ending December 2025, alongside expanding its structured funding facilities beyond $240 million through its subsidiary FSU Capital.

Odyssey Gold Limited has successfully raised approximately $9 million through a placement to fund accelerated development at its Tuckanarra Gold Project in Western Australia.

Avira Resources has completed its acquisition of the Mt Cattlin Gold Project, validating historical data and advancing plans for a significant drilling program in early 2026, backed by a $2.5 million capital raise.

Taruga Minerals has taken a major step forward with a 12-month option to acquire two promising Papua New Guinea projects, backed by a $1.5 million capital raise to accelerate exploration efforts.

Skylark Minerals has acquired a significant gold project portfolio in Côte d’Ivoire, including the flagship Zaranou Project with an inferred resource of 364,600 ounces. The company completed a A$10 million capital raise to fund upcoming exploration activities and has bolstered its technical team ahead of a busy 2026 drilling season.

Galan Lithium has raised A$40 million through an institutional placement to expand production at its Hombre Muerto West project by 30%, aiming for first lithium output in the first half of 2026.

Australian Critical Minerals has raised $3 million through a heavily oversubscribed placement to fund maiden drilling at its promising Flint Gold-Silver Project in Peru.

Loyal Metals has secured and begun unlocking value from the Highway Reward Copper-Gold Mine, revealing substantial unmined mineralisation and advancing lithium projects in North America.

Critical Resources Limited has secured a $1.75 million placement at market price, reinforcing investor confidence as it advances lithium, gold-antimony, and solid-state battery initiatives.

Biotron Limited has completed the acquisition of Sedarex Limited alongside a $2.5 million capital raising, while its lead Hepatitis B drug candidate BIT-HBV001 shows promising preclinical results outperforming current treatments.

GreenTech Metals has fast-tracked its Phase 1 drilling at the Munni Munni PGE-Cu-Ni Project by deploying a second drill rig, aiming to upgrade and potentially expand its historic resource estimate to modern standards.